All tags RabMAb Fully validated in multiple applications, the seventh RabMAb® advantage

ELISA kits

Fully validated in multiple applications, the seventh RabMAb® advantage

Every RabMAb primary antibody is tested in western blot, IHC, ICC/IF, IP and flow cytometry and in multiple species (Human, Mouse, Rat) before release.

RabMAb products benefits from the diverse epitope recognition of the rabbit immune system. Combined with the high specificity of a monoclonal antibody, they deliver high quality results in multiple applications.

  • An average of 3 recommended applications per RabMAb product
  • For IHC, all RabMAb primary antibodies are tested on formalin-fixed and paraffin-embedded (FFPE) human tissue array for more accurate verification of antibody sensitivity and localization.

Validation results for Caspase-3 (Pro) RabMAb primary antibody (ab32150)

RabMAb advantage #7_Caspase 3


Validation data for Caspase-3 (Pro) RabMAb primary antibody (ab32150) on:

  • A) WB on HeLa cell lysate
  • B) IHC on FFPE human cervical carcinoma tissue
  • C) Flow Cyt on Jurkat cells
  • D) ICC on HeLa cells.

Validation results for  AKT1 RabMAb® primary antibody (ab32505)

RabMAb advantage #7_AKT1


Validation data for  AKT1 RabMAb® primary antibody (ab32505) on:

  • A) WB on MCF-7 cell lysate
  • B) IHC on FFPE human prostate carcinoma tissue
  • C) Flow Cyt on MCF-7 cells
  • D) ICC on MCF-7 cells



Sign up